Status:
ENROLLING_BY_INVITATION
Performance of REMS Bone Densitometry in a British Population
Lead Sponsor:
OsteoscanUK Ltd
Conditions:
Bone Densitometry
Eligibility:
FEMALE
20+ years
Brief Summary
Radiofrequency echographic multispectrometry (REMS) is a recently developed technology that uses ultrasound to assess bone density and bone quality. It was launched in 2018 since when OsteoscanUK Ltd ...
Detailed Description
All patients who undergo REMS scans through the OsteoscanUK bone health service, are provided with a comprehensive consent form at least two weeks ahead of the scan and are required to complete the fo...
Eligibility Criteria
Inclusion
- All women over the age of 20 years presenting for a REMS scan
Exclusion
- Lack of consent for the procedure and for the anonymised data to be stored and used for research; Previous bilateral total hip replacements; un controlled spasticity following a neurological injury of development of a neurodegenerative condition
Key Trial Info
Start Date :
November 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 20 2031
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06151353
Start Date
November 21 2023
End Date
May 20 2031
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bragborough Hall Health Centre
Daventry, Northamptonshire, United Kingdom, NN11 7JG